A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W. (Speaker), Schwarze, J. K. (Contributor), Bertels, C. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Vanbinst, A. (Contributor), Everaert, H. (Contributor), Michotte, A. (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Bruneau, M. (Contributor), Forsyth, R. (Contributor), Tuyaerts, S. (Contributor), Neyns, B. (Contributor), Duerinck, J. (Contributor)
- Observerende Klinische wetenschappen
- https://lmmo.research.vub.be/en/home
- Faculteit van de Geneeskunde en Farmacie
- Neurochirurgie
- Spoedgevallen & transit
- Medische Oncologie
- Ondersteunende Klinische wetenschappen
- Radiologie
- Medische Beeldvorming
- nucleaire geneeskunde
- Basis (bio)-medische wetenschappen
- Neuroprotectie & Neuromodulatie
- Anatomo-pathologie
- Neurologie
- Snijdende Klinische wetenschappen
- Experimentele Pathologie
Activiteit: Talk or presentation at a conference